MedTrace Logo

Prolonged Outcomes After Nitric Oxide (PrONOx)

NCT00234247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 652

Last updated 2016-05-13

No results posted yet for this study

Summary

The purpose of this study is to look at the long term consequences of prematurity in infants treated with inhaled nitric oxide (iNO) while in the neonatal intensive care unit.

Conditions

  • Lung Diseases
  • Bronchopulmonary Dysplasia
  • Premature Birth
  • Developmental Disabilities
  • Developmental Delay Disorders

Interventions

OTHER

Long Term Follow-Up

Extended and enhance the follow-up of the NHLBI iNO RCT by assessing the effects of iNO use on: 1.) long term clinical and childhood developmental outcomes; 2.) family impact, and; 3.) healthcare costs of prematurity-associated respiratory failure.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Derek C Angus, MD, MPH · University of Pittsburgh

Eligibility

Max Age
48 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2008-11-30
Completion
2008-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234247 on ClinicalTrials.gov